Clinical Trial Update: Procedural Discomfort Related to Number of Intradetrusor Botox Injections [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether increasing the number of intradetrusor Botox injections affects procedural discomfort for people with overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2025-04-13